We also observed a lower Treg CTLA-4+ frequency in Pool CoV-2-stimulated PBMC from Mild Recovered volunteers who had experienced fatigue, anosmia, and ageusia than in those who had not developed these symptoms (Figure 4B). The gene discussed is CTLA4; the disease is Ageusia.